SCHEMBL17737232

SCHEMBL17737232

O=C1OC(c2ccncc2)c2ccc([N+](=O)[O-])cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
PTPRC P08575 3/20 0.41
S100A4 P26447 2/20 0.41
MAPT P10636 3/20 0.40
CYP19A1 P11511 3/20 0.40
CYP11B1 P15538 3/20 0.40
CYP11B2 P19099 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
CES1 P23141 1/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
CYP3A4 P08684 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10341449 0.81 MAPT (0.43) ALDH1A1PTPRCS100A4MAPTTDP1
SCHEMBL11010158 0.80 ALDH1A1 (0.50) ALDH1A1PTPRCS100A4TDP1BCHE
SCHEMBL14026069 0.76 ALDH1A1 (0.65) ALDH1A1PTPRCS100A4BCHEACHE
SCHEMBL6673213 0.74 ALDH1A1 (0.51) ALDH1A1PTPRCS100A4MAPTTDP1
SCHEMBL4702204 0.74 ALDH1A1 (0.51) ALDH1A1PTPRCS100A4MAPTTDP1
SCHEMBL2532509 0.74 ALDH1A1 (0.51) ALDH1A1PTPRCS100A4MAPTTDP1
SCHEMBL30095404 0.74 ALDH1A1 (0.51) ALDH1A1PTPRCS100A4MAPTTDP1
SCHEMBL15256960 0.70 ALDH1A1 (0.44) ALDH1A1PTPRCS100A4MAPTBCHE
SCHEMBL29122847 0.69 ALDH1A1 (0.46) ALDH1A1PTPRCS100A4MAPTTDP1
SCHEMBL10689729 0.69 ALDH1A1 (0.43) ALDH1A1CYP19A1CYP3A4CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9638690-B2 Compounds and compositions for use as alkylating agent sensors and methods of use thereof THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2017-05-02 US disclosed
US-9638690-B2 Compounds and compositions for use as alkylating agent sensors and methods of use thereof THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2017-05-02 US disclosed
US-20160131641-A1 COMPOUNDS AND COMPOSITIONS FOR USE AS ALKYLATING AGENT SENSORS AND METHODS OF USE THEREOF THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2016-05-12 US disclosed
US-20160131641-A1 COMPOUNDS AND COMPOSITIONS FOR USE AS ALKYLATING AGENT SENSORS AND METHODS OF USE THEREOF THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2016-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160131641-A1 COMPOUNDS AND COMPOSITIONS FOR USE AS ALKYLATING AGENT SENSORS AND METHODS OF USE THEREOF MGMT, MCL1, OGG1 ALDH1A1 2534/4885PTPRC 2076/4885S100A4 1030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.